Tackling the emerging threat of antifungal resistance to human health
2022 · Nature Reviews Microbiology · 1,041 citations
https://doi.org/10.1038/s41579-022-00720-1
T
Tihana Bicanic
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
168
Papers
13.1K
Citations
57
h-index
91
i10-index
Tihana Bicanic is an academic researcher from St George's Hospital. The author has contributed to research in topics: Fungal Infections and Studies & Antifungal resistance and susceptibility & Nail Diseases and Treatments. The author has an h-index of 57, co-authored 143 publications.
ORCID: 0000-0002-2676-838XPapers by this author
worksAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(21)00149-5
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
2018 · New England Journal of Medicine · 393 citations
https://doi.org/10.1056/nejmoa1710922
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 289 citations
https://doi.org/10.1016/s0140-6736(21)01825-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat